Conjupro Biotherapeutics Inc

Conjupro Biotherapeutics Inc


Company description

CSPC Pharmaceutical Group Limited ("CSPC") is a leading pharmaceutical group in China founded on Aug.21, 1997 by the union of four big companies, currently there are approximately 20,000 staff and more than 20 subsidiary companies, the total assets is 4 billion US dollar. CSPC product portfolio covers oncology, antibiotics, cardiovascular and cerebrovascular, CNS, Metabolism, vitamins, etc. CSPC has lunched 6 ANDA products in the US, and more than 70 products are in the R&D pipeline. At least 10 ANDAs are expected to be approved by USFDA. We have three FDA approved facilities for US market. The estimated total asset of CSPC is 4 billion US dollar in 2016. CSPC's mission is to develop good medicine for both China and the world. We create job opportunities not only in China, but also in the United States, CSPC employees all around the world are dedicated ourselves into the career that provide a healthier life for all mankind.

Quick facts

Sales markets Western Europe, Eastern Europe, Middle East, Asia, Australia, North America, Africa, Central/South America

Recently at

16 may 2017

CPhI North America 2017

16-18 May, 2017 Philadelphia, USA We were at stand 3264 See our Exhibitor Profile   See full Exhibitor List
Conjupro Biotherapeutics Inc

Contact information




View all contact information